Contingency Management for Smoking Cessation Among Veterans With Psychotic Disorders
NCT00508560 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23
Last updated 2015-06-26
Summary
This study examines the use of contingent incentives to increase attendance at smoking cessation treatment sessions by smokers with schizophrenia and other psychoses who want to quit smoking. We hypothesize that participants randomized to receive contingent rewards for group attendance will attend more treatment sessions than those in the control group.
Conditions
- Nicotine Dependence
- Psychotic Disorders
Interventions
- BEHAVIORAL
-
Contingency Management
Participants draw from a fishbowl to obtain tokens when they attend a smoking cessation treatment session. The number of draws will be based upon attendance at consecutive sessions. Tokens include messages of encouragement ("Good job!") or VA canteen vouchers of varying monetary value.
- BEHAVIORAL
-
Reward
Participants receive set reward (VA canteen voucher) for each week of smoking cessation treatment they attend. The value of the reward will not change regardless of attendance at consecutive sessions.
Sponsors & Collaborators
-
US Department of Veterans Affairs
lead FED
Principal Investigators
-
Andrew J. Saxon, MD · VA Puget Sound Health Care System
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-07-31
- Primary Completion
- 2012-12-31
- Completion
- 2012-12-31
Countries
- United States
Study Locations
More Related Trials
-
Nicotine and Sensorimotor Replacement for Smoking in Smokers With Schizophrenia
NCT01213524 ·Status: COMPLETED ·Phase: PHASE2
-
Very Low Nicotine Cigarettes in Smokers With Schizophrenia
NCT02019459 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Smokers With and Without Schizophrenia
NCT00770237 ·Status: COMPLETED ·Phase: NA
-
Novel Smoking Cessation Drug for Schizophrenia
NCT02230384 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke
NCT00307203 ·Status: COMPLETED ·Phase: PHASE4
-
Knowledge and Perception of Smoking Risks/Consequences
NCT00686101 ·Status: COMPLETED
-
Patient-Centered Medication Adherence Intervention for Schizophrenia
NCT00144027 ·Status: COMPLETED ·Phase: NA
-
Nicotinic Receptor Density in Smoking and Nonsmoking Schizophrenics
NCT01246128 ·Status: WITHDRAWN
-
Effect of Motivational Therapy on Schizophrenia With Cannabis Misuse
NCT00798109 ·Status: COMPLETED ·Phase: NA
-
The Effects of Nicotine Withdrawal on Reward Responsivity in Schizophrenia
NCT00373126 ·Status: COMPLETED ·Phase: PHASE4
-
Cigarette Smoking in Smokers With and Without Schizophrenia
NCT04001114 ·Status: COMPLETED ·Phase: NA
-
Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
NCT03495024 ·Status: RECRUITING ·Phase: PHASE4
-
Music to Reduce Use of Smoking in Patients With Schizophrenia
NCT03190161 ·Status: COMPLETED ·Phase: NA
-
Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors
NCT00802919 ·Status: COMPLETED ·Phase: PHASE4
-
A Usability Study of a Smoking Cessation Decision Aid in People With a Recent First Episode of Psychosis
NCT01399112 ·Status: COMPLETED ·Phase: NA
-
Motivational Negative Symptoms in Schizophrenia: Intervention and Biomarkers
NCT02386605 ·Status: COMPLETED ·Phase: NA
-
Combining rTMS With Varenicline to Prevent Smoking Lapse in Schizophrenia
NCT03497299 ·Status: WITHDRAWN ·Phase: PHASE2
-
Predictors of Treatment Outcome for Smokers With and Without Schizophrenia
NCT00501007 ·Status: COMPLETED
-
Vaping and Smoking Project in People With Schizophrenia
NCT06944847 ·Status: RECRUITING ·Phase: NA
-
Social Cognition Intervention
NCT01267019 ·Status: COMPLETED ·Phase: NA
-
Effects of Nicotine on Areas of Impaired and Preserved Functioning in Schizophrenia
NCT01034085 ·Status: COMPLETED
-
Acute Effects of Exercise in Smokers With Schizophrenia
NCT01635075 ·Status: COMPLETED ·Phase: PHASE2
-
Relapse Prevention in First Episode Schizophrenia: a 5 Year Trial
NCT01936220 ·Status: UNKNOWN ·Phase: NA
-
Enhancing Motivation in Recent Onset Schizophrenia
NCT01817387 ·Status: TERMINATED ·Phase: NA
-
Family Motivational Intervention in Schizophrenia
NCT01167556 ·Status: UNKNOWN ·Phase: NA